Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and End-Stage Renal Disease (MK-0431-073 AM1)
Status:
Completed
Trial end date:
2011-03-14
Target enrollment:
Participant gender:
Summary
The purpose of the study is to compare sitagliptin and glipizide in lowering blood sugar in
participants with type-2 diabetes mellitus (T2DM) and end-stage renal disease on dialysis who
do not have adequate glycemic control.